Asthma and Allergy News and Research

Thunderstorms and Asthma: An Unexpected Connection

In November 2016, a surprising event occurred in Melbourne, Australia. During an outbreak of thunderstorms, thousands of people had sudden asthma attacks around the same time. The strange weather event overwhelmed emergency facilities and personnel. Nine people died from the event. The phenomenon is called thunderstorm asthma. Experts in Australia and Europe have been studying thunderstorm asthma for years. But we don’t hear much about it in the United States. Does that mean Americans won’t...

Report Finds Two Medicines to Be a Good Long-Term Option for Atopic Dermatitis

The Institute of Clinical and Economic Review (ICER) found the medicines dupilumab and crisaborole to offer effective long-term treatment of atopic dermatitis, also known as eczema . A portion of the press release is below. [PRESS RELEASE] Boston, Mass., June 8, 2017 – The Institute of Clinical and Economic Review (ICER) has issued a Final Evidence Report that concludes that dupilumab (Dupixent ® , Regeneron and Sanofi) offers good long-term value for patients with moderate-to-severe atopic...

UPDATED: GlaxoSmithKline Recalling Ventolin Inhalers for Possible Package Leakage

Note: As of May 16, 2017, GlaxoSmithKline expanded their recall. Additional lot numbers have been added below. GlaxoSmithKline (GSK) issued a voluntary Class II recall on April 4, 2017 for three lots of Ventolin® HFA 200D Inhalers from U.S. hospitals, pharmacies, retailers and wholesalers as a precautionary measure. It is not a consumer recall.

School-Based Respiratory Health Management Act Introduced to House

[Press Release] Roe, Hoyer Introduce School-Based Respiratory Health Management Act Washington, May 2, 2017 | Lani Short (202-225-6356) WASHINGTON, DC – Today, Rep. Phil Roe, M.D. (R-TN) and House Democratic Whip Steny H. Hoyer (D-MD) introduced H.R. 2285, the School-Based Respiratory Health Management Act, legislation that encourages states to help ensure students with reversible lower airway disorders, such as asthma, have assistance at school with managing their chronic disease and can...

Teva Launches AirDuo™ RespiClick® and its Authorized Generic

[Press Release] Teva Launches AirDuo™ RespiClick® and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol First and Only Generic Fluticasone Propionate and Salmeterol (ICS/LABA) Inhaler Available in the U.S. JERUSALEM, April 20, 2017 – Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the simultaneous launch of AirDuo™ RespiClick® (fluticasone propionate and salmeterol) inhalation powder and its authorized generic for the treatment...

Asthma and Allergy Research Review January-March 2017

The Asthma and Allergy Foundation of America will recap some of the top research about allergies and asthma every three months. Here is a look at studies reported between January and March. Read about how treating homes for cockroaches can improve children's asthma, a possible link between insomnia and developing asthma, the safety of allergy immunotherapy and more.

New Eczema Drug Dupixent Approved by FDA

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids.

GlaxoSmithKline Study Shows Nucala Improves Quality of Life, Lung Function in Severe Asthma

GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and statistically significant improvements in their health-related quality of life and lung function, when compared to patients treated with placebo and standard of care. These results are from the phase IIIb MUSCA study (NCT02281318, 200

Black Children Six Times More Likely to Die of Asthma

There is no cure for asthma, but with the proper diagnosis, medication and an asthma management plan, symptoms can be controlled. When not properly controlled asthma can be deadly. A study being presented at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting called “Where Do Children with Asthma Die? A National Perspective from 2003 to 2014” seeks to address where and which demographics of children are dying because of asthma in the United States.